Status:
COMPLETED
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Pain, Postoperative
Postoperative Nausea and Vomiting
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % versus Ropivacaine 0.2 % versus Placebo in patients undergoing elective caesarean section. The hypothesis ...
Eligibility Criteria
Inclusion
- eligible for elective caesarean section
- able to speak and understand Danish
- able to give informed consent
Exclusion
- alcohol or medical abuse
- allergies to local anesthetics
- age \< 18 years
- intolerance to opioids
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00891540
Start Date
July 1 2009
End Date
May 1 2010
Last Update
June 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre University Hospital
Copenhagen, Hvidovre, Denmark, 2650